Bankruptcy News

We've summarized the latest docket activity and news for publicly traded companies currently operating under U.S. Bankruptcy Court protection.

Bankruptcy/Chapter 11 / Healthcare Equipment & Services

IntraOp Medical Chapter 11 Petition Filed

IntraOp Medical filed for Chapter 11 protection with the U.S. Bankruptcy Court in the Northern District of California, case number 13-53791. The Company, which provides technology solutions for cancer treatment, is represented by Robert L. Eisenbach, III of Cooley. The Company also announced that it has reached an agreement through which an entity backed by a group of institutional investors will acquire substantially all of its assets in a transaction valued at approximately $15 million, plus the assumption of certain liabilities. The purchase agreement comprises the initial stalking horse bid for a Court-supervised auction process, under Section 363 of the Bankruptcy Code. “IntraOp Medical had a strong fiscal year in 2012, with 13 machines shipped and positive earnings over $1 million before taxes and depreciation, but was unable to produce sufficient free cash flow to service its existing debt,” said John Powers, C.E.O. of IntraOp Medical. “In addition, the company did not have the cash resources to counteract a slowdown in 2013 driven by the decline in the European economy and uncertainty over Healthcare reform in the United States.” In addition to the stalking horse bid, the bidder has committed to provide debtor in possession financing to provide sufficient liquidity for ongoing operations through the process.

Read more Bankruptcy News

Identify & Profit from Distressed Investing

Free Report: Turnaround Investing Mistakes

Turnaround Investing Blog

Turnaround Investing Blog

Turnaround Investing Philosophy: 32 Years Later, Some Things Never Change

Recently I was asked how my investing perspective changed over the 32 years of publishing The Turnaround Letter. It's a fascinating question because change is constant, and often beneficial (although that's not a given) in the business world. If change is the norm, can investing principles stay constant? I firmly believe that they can. Read More.

EV/EBITDA: What Is It & Why Are We Using It More?

In reading recent editions of The Turnaround Letter, you have probably noticed that we are increasingly using EV/EBITDA as a valuation measure, rather than the better-known price/earnings multiple.  We thought it might be useful to describe this measure and why we like it.

Read More.

Turnaround Letter Stock Pick Named Top Performer of 2017


stock market advicex


What Last Year's Top Stock Pickers Are Buying in 2018


This Forbes write-up follows up on the recent Top Stock Tips report--naming The Turnaround Letter's Crocs recommendation the top performer of 2017: With 90% gains, CROX beat out 100 other investment ideas included in the report; and the stock continues to have value investing appeal, according to Putnam.


George notes, "We see additional upside for the stock in 2018 as management's efforts continue to bear fruit, though the gains will likely be more muted than we saw in 2017."